Company

Cancer’s Vulnerability is Our Strength

MANAGEMENT

Markus Renschler, MD
Markus Renschler, MDPresident & Chief Executive Officer
Susan Doleman
Susan DolemanVP, Clinical Operations
Paul Secrist, Ph.D.
Paul Secrist, Ph.D. Chief Scientific Officer
Barbara Wan, PhD
Barbara Wan, PhDVP, Research & Development Project Leadership
Tom O'Shea, PhD
Tom O'Shea, PhDSVP, Clinical Pharmacology & Preclinical Development
Judson Englert, M.D., Ph.D.
Judson Englert, M.D., Ph.D.VP, Clinical Research & Development
Jean-Marc Lapierre, PhD
Jean-Marc Lapierre, PhDVP, Chemistry
Andrew Gengos
Andrew GengosChief Business Officer
David Gaiero
David GaieroVP, Finance

BOARD OF DIRECTORS

Racquel Bracken
Racquel BrackenVenrock
Markus Renschler, MD
Markus Renschler, MDPresident & Chief Executive Officer
Jean George, MBA
Jean George, MBALightstone Ventures
Timothy Romberger
Timothy RombergerFounder Cyteir Therapeutics & TRC Advisory
Joseph S. Zakrzewski
Joseph S. ZakrzewskiIndependent Investor & Chairman, Cyteir Therapeutics
Karen Hong, PhD
Karen Hong, PhDNovo Ventures
Janwillem Naesens, MSc, MBA
Janwillem Naesens, MSc, MBADROIA